These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9280698)

  • 1. [Antimicrobial therapy in neutropenia].
    Maschmeyer G; Vogt K; Hahn H; Dörken B
    Dtsch Med Wochenschr; 1997 Jul; 122(27):864-9. PubMed ID: 9280698
    [No Abstract]   [Full Text] [Related]  

  • 2. [Infection therapy in neutropenia].
    Adam D
    Dtsch Med Wochenschr; 1999 Apr; 124 Suppl 1():S2. PubMed ID: 10410647
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antimicrobial therapy for fever of unknown origin in neutropenia. Standard recommendations of the Work Group of Infections in Hematology and Oncology of the German Association of Hematology and Oncology].
    Link H; Blumenstengel K; Böhme A; Cornely O; Kellner O; Nowrousian MR; Ostermann H; Schiel X; Wilhelm M
    Dtsch Med Wochenschr; 1999 Apr; 124 Suppl 1():S3-8. PubMed ID: 10410648
    [No Abstract]   [Full Text] [Related]  

  • 4. [Empirical antimicrobial therapy in a patient with neutropenia].
    Anttila VJ; Ruotsalainen E
    Duodecim; 2002; 118(21):2241-7. PubMed ID: 12486961
    [No Abstract]   [Full Text] [Related]  

  • 5. [Empirical antimicrobial therapy in neutropenic patients].
    Maschmeyer G
    Ther Umsch; 1996 Nov; 53(11):854-62. PubMed ID: 8984691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever.
    Jun HX; Zhixiang S; Chun W; Reksodiputro AH; Ranuhardy D; Tamura K; Matsumoto T; Lee DG; Purushotaman SV; Lim V; Ahmed A; Hussain Y; Chua M; Ong A; Liu CY; Hsueh PR; Lin SF; Liu YC; Suwangool P; Jootar S; Picazo JJ
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S128-32; discussion S133-40. PubMed ID: 16253480
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy of bacterial infections in acute leukemia.
    Bodey GP
    Leukemia; 1992; 6 Suppl 2():17-21. PubMed ID: 1578924
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylactic antimicrobial agents and the importance of fitness.
    Baden LR
    N Engl J Med; 2005 Sep; 353(10):1052-4. PubMed ID: 16148291
    [No Abstract]   [Full Text] [Related]  

  • 9. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia].
    Karthaus M; Meran JG; Geissler RG; Böhme A; Jürgens H; Ganser A
    Wien Med Wochenschr; 1998; 148(18):427-32. PubMed ID: 9888179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of infection in children with bone marrow failure.
    Hann IM
    Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):441-56. PubMed ID: 11030044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I; Sanz MA
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of infections in patients with acute leukemia.
    Sarkodee-Adoo CB; Merz WG; Karp JE
    Oncology (Williston Park); 2000 May; 14(5):659-66, 671-2; discussion 672-7. PubMed ID: 10853459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of infections in patients with neutropenia (a review of the literature with the inclusion of the authors' own data)].
    Ptushkin VV; Bagirova NS; Volkova MA
    Ter Arkh; 1998; 70(7):83-7. PubMed ID: 9742648
    [No Abstract]   [Full Text] [Related]  

  • 15. Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia.
    Bal AM; Gould IM
    Int J Antimicrob Agents; 2007 May; 29(5):501-9. PubMed ID: 17346939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.
    Kalman D; Barriere SL
    J Infect Dis; 1991 Jan; 163(1):201-3. PubMed ID: 1984470
    [No Abstract]   [Full Text] [Related]  

  • 17. [Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society].
    Maschmeyer G; Link H; Hiddemann W; Meyer P; Helmerking M; Eisenmann E; Schmitt J; Adam D
    Med Klin (Munich); 1994 Mar; 89(3):114-23. PubMed ID: 8196571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hematopoietic growth factors in iatrogenic neutropenia in oncology].
    Klastersky J
    Rev Mal Respir; 1995; 12(5):407-8. PubMed ID: 8560070
    [No Abstract]   [Full Text] [Related]  

  • 19. From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.
    Hughes WT; Armstrong D; Bodey GP; Feld R; Mandell GL; Meyers JD; Pizzo PA; Schimpff SC; Shenep JL; Wade JC
    J Infect Dis; 1990 Mar; 161(3):381-96. PubMed ID: 2179420
    [No Abstract]   [Full Text] [Related]  

  • 20. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.